Posts

Showing posts with the label Recent Regulatory Updates in Pharmaceutical Microbiology

Recent Regulatory Updates in Pharmaceutical Microbiology

Recent Regulatory Updates in Pharmaceutical Microbiology (2025) 1. Emphasis on Data Integrity and Automation Regulatory agencies are increasingly prioritizing data integrity and traceability in pharmaceutical microbiology. The adoption of automated microbiological processes is being encouraged to enhance compliance and reduce human error. For instance, the European Pharmacopoeia has updated chapters to include alternative microbiological methods such as solid-phase cytometry for sterility testing. Read more 2. Harmonization of Pharmacopoeial Standards International pharmacopoeias are revising chapters related to microbiological quality control, standardizing methods for bioburden testing, endotoxin detection, and pyrogenicity assessments. Learn more 3. Integration of Artificial Intelligence in Regulatory Frameworks The EU has intro...

Popular posts from this blog

Too Numerous To Count (TNTC) & Too Few To Count (TFTC) in Microbiology: Meaning, Limits, Calculations, and GMP Impact

Non-Viable Particle Count (NVPC) in Cleanrooms: Principles, Methods & GMP Requirements

USP 41; Balances Explained (2026): Measurement Uncertainty, Minimum Weight, Audit Readiness; Why USP Revised the Rule